Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Ossur Hf: Insider trading


Posted on: 30 Oct 17

Announcement Össur hf. No. 78/2017

 

Viðskipti með eigin bréf/transaction in own financial instruments

 

Nafn/Name:

Össur hf.

Dagsetning viðskipta/Date of transaction:

30 October 2017

Kaup eða sala/Buy or Sell:

Sell

Tegund fjármálagernings/Type of instrument:

Equities

Fjöldi hluta/Number of shares:

144,753

Gengi/Verð pr. Hlut/Price:

DKK 29.43

Fjöldi hluta eftir viðskipti/Primary insider's holdings after the transaction:

8,656,632

Dagsetning lokauppgjörs/Date of settlement:

1 November 2017

Ástæður viðskipta/Reason for transaction:

The shares are delivered in relation to an acquisition of a small prosthetics manufacturer. The share price is DKK 29.43, the Company's average share price on Nasdaq Copenhagen in the last 20 trading days.

GlobeNewswire
globenewswire.com

Last updated on: 31/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.